Since 1985, Professor Hans Vasen is staff member of the Department of Gastroenterology & Hepatology of the Leiden University Medical Centre (LUMC) as well as Medical Director of the Dutch Hereditary Cancer Registry. In 2000, Vasen received the Frieda den Hartog Jager Penning (Dutch Association Gastroenterology & Hepatology). In 2017, his study , “Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.” was selected for inclusion in the JCO's report, Clinical Cancer Advances 2017: ASCO’s Annual Report on Progress Against Cancer. The report is an independent annual review of the year’s major achievements and emerging trends in clinical cancer research and care.

More information about Hans Vasen

Since 1985, Professor Hans Vasen is staff member of the Department of Gastroenterology & Hepatology of the Leiden University Medical Centre (LUMC) as well as Medical Director of the Dutch Hereditary Cancer Registry. In 2000, Vasen received the Frieda den Hartog Jager Penning (Dutch Association Gastroenterology & Hepatology). In 2017, his study , “Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.” was selected for inclusion in the JCO's report, Clinical Cancer Advances 2017: ASCO’s Annual Report on Progress Against Cancer.  The report is an independent annual review of the year’s major achievements and emerging trends in clinical cancer research and care.

Prevention of Hereditary Cancer

In 2009, he was appointed professor of `Prevention of Hereditary Cancer" at the University of Leiden. The research of professor Vasen focuses mainly on three hereditary cancer syndromes, i.e., Lynch syndrome, familial polyposis and hereditary pancreatic cancer. Part of the research is conducted in collaboration with the Dutch Hereditary Cancer Registry (Stichting Opsporing Erfelijke Tumoren (StOET)).

Academic career

After completion of his training as internist In 1985, he was appointed as Medical Director of the Hereditary Cancer Registry and stafmember at the Department of Gastroenterology & Hepatology of the Leiden University Medical Centre and the Department of Endocrinology of the University Medical Centre Utrecht. In a few years, he succeeded to develop the Dutch Hereditary cancer Registry, one of the first and largest registries worldwide. In 1989, he completed his thesis "Screening for Hereditary Cancer" (University of Utrecht). Since 2014, he is a certified endoscopist of the Dutch Poplation Screening program. 

Prizes and honourable appointments

Since 2000 he is one of the Editors-in-Chief of Familial Cancer (Springer publishers).

Publications